Woodline Partners LP Bicycle Therapeutics PLC Put Options Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCYC
# of Institutions
100Shares Held
42.7MCall Options Held
15.6KPut Options Held
27.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$92.6 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$31.4 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$29.4 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$22.7 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$22.6 Million0.12% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $253M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...